K. D. Rainsford, editor-in-chief, quarterly, $177, Dordrecht, the Netherlands, Kluwer Academic Publishers, 1991-.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Students of the literature of inflammation and its pharmacological control now have a new international, interdisciplinary journal. Blending several disciplines, Inflammopharmacology reports clinical and experimental research on drugs, their actions, therapeutic efficacy, and safety when used in the treatment of various inflammatory diseases. According to Kluwer's 1992 Journals in Medicine catalogue, the journal covers experimental development of in vitro systems and in vivo animal models; assay methodologies; biochemical, immunological, and pharmacological studies; clinical pharmacology and therapeutics; drug-induced side effects; comparative drug studies and trials; and novel approaches toward the therapy of inflammatory conditions. The journal should appeal to both investigators and practitioners.
Spearheaded by Rainsford, editorial responsibility lies with 31 experts worldwide. Authors will appreciate the short turnaround time for manuscript review, a month or less from the date of submission. Its refereeing policy is explicitly outlined in the instructions for authors, which speak in defense of anonymous review
Carlson BA, LeRoy EC. Inflammopharmacology. JAMA. 1993;270(10):1254-1255. doi:10.1001/jama.1993.03510100104046